Key facts
- HeartHero’s last known valuation is $20.5M (Aug 2019).
- It has raised $18.5M across 3 recorded rounds; the latest was Seed Round ($4.0M) in Jun 2025.
- Notable investors include PIC Investment Group, AngelMD, COPIC Companies, Colorado Venture Capital Authority.
- HeartHero has filed 2 Form Ds with the SEC since 2023, most recently Nov 2024 ($3.8M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for HeartHero
Funding rounds
3 roundsAbout HeartHero
Developer of an automated external defibrillator (AED) intended to empower anyone, anywhere to save a life from sudden cardiac arrest. The company's defibrillator is a portable, easy-to-use device powered by a store-bought battery. It can automatically diagnose life-threatening cardiac arrhythmias, including ventricular fibrillation (VF) and pulseless ventricular tachycardia, and treat them through defibrillation, enabling patients to receive help during sudden cardiac arrest.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2016
- Employees
- 11
- Website
- hearthero.com/
- Ownership
- Privately Held (backing)
HeartHero doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HeartHero shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HeartHero in its N-PORT filings yet. We sweep new filings monthly.